ARTICLE | Distillery Therapeutics
Cancer
November 13, 2018 6:49 PM UTC
Cell studies identified a dual HDAC6/proteasome inhibitor that could help treat leukemia and MM. A chemical reaction coupling a N-hydroxybenzamide-based HDAC inhibitor to a tris(oxo-4-phenylbutan-2-yl...